Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Combined deletion

Von Schnakenburg C, Hulton SA, Milford DV, Roper HP, Rumsby G Variable presentation of primary hyperoxaluria type 1 in two patients homozygous for a novel combined deletion and insertion mutation in exon 8 of the AGXT gene. Nephron 1998 78 485-488. [Pg.518]

Relational database models utilize memory very efficiently, avoiding repetition of data. It is possible to extract both individual data elements and combinations of them from a table. The main advantage of this structure is that it offers the possibility ofehanging the structure of the database (adding or deleting tables) without... [Pg.235]

It should be emphasized that the proeess of deleting or erossing off entries in various Ml, Ms boxes involves only counting how many states there are by no means do we identify the particular L,S,Ml,Ms wavefunctions when we cross out any particular entry in a box. For example, when the piapoP product is deleted from the Ml= 1, Ms=0 box in accounting for the states in the level, we do not claim that piapoP itself is a member of the level the poOtpiP product state could just as well been eliminated when accounting for the P states. As will be shown later, the P state with Ml= 1, Ms=0 will be a combination of piapoP and pootpiP. ... [Pg.253]

A unique feature of the interaction of the hormone and PLR is at the beginning of the F-G loop in the C-terminal domain. In HGR the sequence is Arg-Asn-Ser whereas in PLR it is Asp-His-deletion. This loop interacts with His 18 and Glu 174 of the hormone. In PLR the orientation of this loop is such that the Asp and His residues, in combination with His and Glu from the hormone, form a strong binding site for a zinc atom that links the hormone and the receptor (Figure 13.23b). The presence of zinc increases the affinity of the hormone for the receptor in vitro by a factor of 10,000. As shown by mutagenesis studies His 18 and Glu 174 of the hormone are important for the tight binding to PRL but not to GHR. [Pg.270]

The graph g is not unique. An alternative, and simpler , finite STG (call it g) is shown in figure 6.2-b. It is obtained from g by deleting all of the equivalent nodes in g, where two nodes are defined to be equivalent if all paths passing through them carry exactly the same symbols. In our example, nodes q and 02 are equivalent and can thus be combined into a single node. [Pg.300]

Demonstrate that user ID (an essential element of user ID/PW combination comprising the electronic signature) is not reusable by deletion/recreation, overwrite, or other means. [Pg.644]

The combination of PCA and LDA is often applied, in particular for ill-posed data (data where the number of variables exceeds the number of objects), e.g. Ref. [46], One first extracts a certain number of principal components, deleting the higher-order ones and thereby reducing to some degree the noise and then carries out the LDA. One should however be careful not to eliminate too many PCs, since in this way information important for the discrimination might be lost. A method in which both are merged in one step and which sometimes yields better results than the two-step procedure is reflected discriminant analysis. The Fourier transform is also sometimes used [14], and this is also the case for the wavelet transform (see Chapter 40) [13,16]. In that case, the information is included in the first few Fourier coefficients or in a restricted number of wavelet coefficients. [Pg.236]

Trueness At LCL and two higher levels >1 Rephcate in >3 laboratories at each level >4 commodities (typical matrices) Mean recovery 70-110% calculated for each analyte-commodity-concentration combination Outhers should be removed (the number of deleted suspicious recovery data must not exceed 20%)... [Pg.126]

Hereditary methemoglobinemia is classified into three types a red blood cell type (type I), a generalized type (type II), and a blood cell type (type HI). Enzyme deficiency of type I is limited to red blood cells, and these patients show only the diffuse, persistent, slate-gray cyanosis not associated with cardiac or pulmonary disease. In type II, the enzyme deficiency occurs in all cells, and patients of this type have a severe neurological disorder with mental retardation that predisposes them to early death. Patients with type III show symptoms similar to those of patients with type I. The precise nature of type III is not clear, but decreased enzyme activity is observed in all cells (M9). It is considered that uncomplicated hereditary methemoglobinemia without neurological involvement arises from a defect limited to the soluble cytochrome b5 reductase and that a combined deficiency of both the cytosolic and the microsomal cytochrome b5 reductase occurs in subjects with mental retardation. Up to now, three missense mutations in type I and three missense mutations, two nonsense mutations, two in-frame 3-bp deletions, and one splicing mutation in type n have been identified (M3, M8, M31). [Pg.33]

Low levels or absence of adenosine deaminase (ADA) is associated with one form of severe combined immunodeficiency disease (SCID) characterized by B-andT-lymphocyte dysfunction due to toxic effects of deoxyadenosine (HI9). Most patients present as infants with failure to thrive, repeated infections, severe lymphopenia, and defective cellular and humoral immunity. Disease severity is correlated with the degree of deoxyadenosine nucleotide pool expansion and inactivation of S-adenosylhomocysteine hydrolase in red blood cells. Up to now, more than 40 mutations have been identified (A4, H20, S5, S6). The majority of the basic molecular defects underlying ADA deficiency of all clinical phenotypes are missense mutations. Nonsense mutations, deletions ranging from very large to single nucleotides, and splicing mutations have also been reported. It is likely that severe... [Pg.33]

Reverse genetics has been applied to diseases such as Duchenne muscular dystrophy and cystic fibrosis, in which the responsible enzymes are unknown and the disease results from a significant deletion. By combining RFLP analysis with cytogenetics, it has been possible to increasingly narrow the location of the defective genes to small regions on the affected chromosomes. [Pg.256]


See other pages where Combined deletion is mentioned: [Pg.633]    [Pg.1259]    [Pg.189]    [Pg.178]    [Pg.633]    [Pg.1259]    [Pg.177]    [Pg.418]    [Pg.158]    [Pg.307]    [Pg.377]    [Pg.279]    [Pg.256]    [Pg.633]    [Pg.1259]    [Pg.189]    [Pg.178]    [Pg.633]    [Pg.1259]    [Pg.177]    [Pg.418]    [Pg.158]    [Pg.307]    [Pg.377]    [Pg.279]    [Pg.256]    [Pg.447]    [Pg.1296]    [Pg.768]    [Pg.114]    [Pg.230]    [Pg.2091]    [Pg.363]    [Pg.393]    [Pg.138]    [Pg.302]    [Pg.363]    [Pg.136]    [Pg.76]    [Pg.312]    [Pg.126]    [Pg.1068]    [Pg.117]    [Pg.20]    [Pg.230]    [Pg.218]    [Pg.61]    [Pg.218]    [Pg.53]    [Pg.220]    [Pg.61]    [Pg.85]    [Pg.87]   
See also in sourсe #XX -- [ Pg.288 ]




SEARCH



Delete

Deletions

© 2024 chempedia.info